Coronavirus Live Count Map India
remove_red_eye 678 Views
COVID-19 Vaccine Updates
Bacteria that travel across continents in atmospheric dust can impact climate & ecosystems
LONDON: Some bacteria can travel from one continent to another hidden in atmospheric dust, according to a new study which says these microbes may not only affect human and animal health, but also impact climate and ecosystems. The research, published in the journal Atmospheric Research, deciphered the mystery of the transport of microorganisms across continents via giant atmospheric particles called iberulites that could be inhaled by humans. ....read more
CMAAO Coronavirus Facts and Myth Buster: Why Certain COVID Patients Die
With input from Dr Monica Vasudev1.Advancing age and underlying medical problems explain only part of the phenomenon.2.Some people, especially men, succumb because their immune systems are hit by friendly fire.3.A study in Science revealed that 10% of around 1,000 COVID patients who developed life-threatening pneumonia had antibodies that disable interferons. These autoantibodies were not found in 663 people with mild or asymptomatic COVID infections. Only four of 1,227 healthy individuals were found to have the autoantibodies. ....read more
CMAAO Coronavirus Facts and Myth Buster: COVID Updates
1206: Why Viruses Spread More Easily in Winter?1.In winters, people tend to spend more time indoors, where ventilation is poor and we’re in closer proximity to other people.2.The Air Outside is Less Humid: Viruses stay stable and linger for longer when the air is less humid.3.Nasal Membranes Are Drier: Feels dry and cracked. These cracks make you more vulnerable to infection. Staying hydrated and using a saline nasal spray can help. ....read more
Fasting and starvation are two different terms commonly confused with each other. Starvation means not eating or drinking altogether, while fasting means control and restrain of five sensory and five motor senses. ....read more
Video of The day
Healthcare News Monitor
WASHINGTON : Zoom fatigue? Isolation from colleagues? A craving for lamb shawarma from the downtown food truck? Months into a pandemic that has changed work-life balance into a work-life MC Escher drawing - with the end of one and the beginning of the other now indistinguishable - Americans say theyve actually adapted fine to home offices and dining room table workstations, and most want to continue working from home after the pandemic.
HYDERABAD: As the founder of Shantha Biotechnics, one of the first Indian companies to develop vaccines indigenously and the only one to have developed a vaccine independently, K I Varaprasad Reddy has a unique insight into the ongoing global race to launch a Covid-19 vaccine. In an interview with Swati Bharadwaj, the Padma Bhushan awardee talks about the challenges ahead. The world is looking to India and vaccine capital Hyderabad to churn out Covid vaccines. What challenges do Indian vaccine makers face?
Incyte announced that the Phase 3 RUXCOVID study evaluating the safety and efficacy of ruxolitinib (Jakafi), a JAK1/JAK2 inhibitor, plus standard-of-care (SoC) as a treatment for patients 12 years and older with COVID-19 associated cytokine storm did not meet its primary endpoint. Initial data show that there was no reduction in the proportion of patients receiving ruxolitinib plus SoC who experienced severe complications including death, respiratory failure requiring mechanical ventilation or admission to the intensive care unit (ICU) care by Day 29, compared to SoC treatment alone (12.0% vs. 11.8% [OR: 0.91 [95% CI: 0.48-1.73], P=0.769, respectively)1.
By John Geddie and Anshuman DagaSINGAPORE (Reuters) -Singapore became on Monday the first Asian country to approve Pfizer-BioNTechs coronavirus vaccine and said it expects to start receiving shots by the end of the year. Prime Minister Lee Hsien Loong, 68, said he would be among the early recipients in the city-state of 5.7 million people, which has one of the lowest fatality rates globally from the coronavirus. The government said it expects to have secured enough vaccines for everyone by the third quarter of next year.